Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 24, 2026
Why Is Oracle Corporation (ORCL) Stock Down -5.68% Today?

Why Is Oracle Corporation (ORCL) Stock Down -5.68% Today?

Key Takeaways

  • Oracle Corporation (ORCL) shares fell about 5.68% on Thursday, trading near $136.35 versus a prior close of $144.56.
  • The primary catalyst was a report that Oracle sent a "force majeure" notice to the developer of its "Project Jupiter" data center in New Mexico.
  • The move reignited investor concerns about execution risk in Oracle's massive AI infrastructure buildout and its heavy capital spending.
  • The decline was largely company-specific, with cloud peers such as Snowflake and CoreWeave showing minimal moves.
  • Traders are now watching for confirmation on whether the project is actually delayed and how any timeline slippage affects Oracle's AI revenue ramp.

Opening Summary

Oracle Corporation (ORCL), the enterprise software and cloud infrastructure giant, fell sharply in Thursday's session after a report raised fresh doubts about a key data-center project underpinning its artificial-intelligence ambitions. The stock dropped about 5.68%, trading near $136.35, down from a prior close of $144.56, confirming a clear downward move. Markets attributed the decline primarily to news that Oracle had sent a "force majeure" notice to the developer of a controversial New Mexico data center tied to the Stargate venture involving Oracle, OpenAI, and SoftBank.

Force Majeure Notice on "Project Jupiter"

The immediate trigger was a report that Oracle is seeking to shield itself from potential cost increases and delay payments if a large New Mexico data-center project, known as Project Jupiter, is unable to bring capacity online in 2028 as planned. The facility is linked to Stargate, the high-profile AI infrastructure initiative involving OpenAI and SoftBank. Investors read the notice as a signal that the project faces meaningful risk of delay amid local opposition, permitting hurdles, power-availability constraints, and financing pressure.

The concern for the market is straightforward: Oracle has been racing to expand data-center capacity to serve enormous AI cloud contracts. If capacity is delayed, the associated revenue ramp could slip even as development costs and commitments continue. That dynamic directly threatens the profit narrative that has supported ORCL shares during its aggressive infrastructure push.

Renewed Execution and Balance-Sheet Concerns

The force majeure report landed on an already sensitive area of the investment debate. Oracle has posted exceptionally strong cloud growth—including triple-digit expansion in cloud infrastructure revenue—and has built a backlog measured in the hundreds of billions of dollars. Yet the company is simultaneously spending heavily on data centers, which has pressured free cash flow and, at times, investor confidence in the balance sheet.

The New Mexico development therefore feeds directly into the bearish argument that Oracle's capital-intensive strategy carries meaningful execution risk. A delay in a marquee project would not necessarily halt growth, but it raises questions about how quickly the company can convert its substantial AI backlog into revenue and cash flow.

Market Context and Trading Activity

Thursday's decline was notable for being largely company-specific rather than a reflection of broad sector weakness. While ORCL fell more than 5%, other cloud and AI-infrastructure names showed only modest moves, with peers such as Snowflake and CoreWeave trading near flat. That divergence underscores that the selling was driven by Oracle's own project news rather than a wider rotation out of technology or cloud stocks.

The stock gapped lower in premarket trading and remained under pressure after the open, with the shares touching their lowest levels in roughly seven weeks. The move reflects how sensitive ORCL has become to any headline surrounding its data-center timeline, given the scale of capital already committed.

What Comes Next for ORCL

The near-term focus will be on whether the Project Jupiter situation represents a genuine delay or simply a contractual negotiation over how risk is shared. Oracle has not confirmed that the data center is actually delayed, and the notice may be a protective step rather than proof of a setback. Investors will also watch for any formal company response, as well as updates on financing and permitting for the project.

Beyond this specific development, attention remains on Oracle's ability to convert its AI backlog into revenue, the pace of its capital expenditures, and its upcoming fiscal second-quarter results, expected around December. Broader sector developments—including electricity availability, local opposition to data centers, and hyperscaler competition—will continue to shape sentiment. Risks remain on both sides: strong AI demand supports the growth story, while execution and cash-flow concerns continue to weigh on valuation.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots that have demonstrated standout performance under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, and only the strongest performers are featured in this section. The bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving traders a way to explore data-driven approaches across different market environments.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ORCL

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


ORCL in upward trend: 10-day moving average crossed above 50-day moving average on August 19, 2026

The 10-day moving average for ORCL crossed bullishly above the 50-day moving average on August 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

ORCL moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCL advanced for three days, in 227 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

The Aroon Indicator entered an Uptrend today. In 189 of 287 cases where ORCL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORCL as a result. In 45 of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.

The Moving Average Convergence Divergence Histogram (MACD) for ORCL turned negative on September 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 23 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

ORCL broke above its upper Bollinger Band on September 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 24 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.299) is normal, around the industry mean (20.388). P/E Ratio (23.386) is within average values for comparable stocks, (157.795). Projected Growth (PEG Ratio) (0.833) is also within normal values, averaging (3.678). Dividend Yield (0.013) settles around the average of (0.004) among similar stocks. P/S Ratio (5.858) is also within normal values, averaging (103.889).

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. ORCL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 79 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Microsoft Corp (NASDAQ:MSFT), Oracle Corp (NYSE:ORCL), Palo Alto Networks Inc (NASDAQ:PANW), Crowdstrike Holdings Inc (NASDAQ:CRWD), Block Inc (NYSE:XYZ), Twilio (NYSE:TWLO), NetApp (NASDAQ:NTAP), MongoDB (NASDAQ:MDB), Okta (NASDAQ:OKTA), Zscaler (NASDAQ:ZS).

Industry description

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

Market Cap

The average market capitalization across the Computer Communications Industry is 35.27B. The market cap for tickers in the group ranges from 48.8K to 3.72T. MSFT holds the highest valuation in this group at 3.72T. The lowest valued company is WMHI at 48.8K.

High and low price notable news

The average weekly price growth across all stocks in the Computer Communications Industry was -0%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 28%. AIXC experienced the highest price growth at 73%, while HUBC experienced the biggest fall at -47%.

Volume

The average weekly volume growth across all stocks in the Computer Communications Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was 28% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 70
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 91
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
ORCL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of a diversified line of business software products

Industry ComputerCommunications

Industry
Packaged Software
Address
2300 Oracle Way
Phone
+1 737 867-1000
Employees
141000
Web
https://www.oracle.com
Interact to see
Advertisement
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.